Interviewed at the COST conference on Personalised Medicine, Adriano Henney comments on the relationship between physiology and in silico biology. He also discusses drug safety issues related to in silico methods.
COST - European Cooperation in Science and Technology - organised the 'Personalised Medicine: Better Healthcare for the Future' event from 17 to 22 June 2012 in Cyprus to bring together researchers, scientists, policy-makers, patients' associations and stakeholders to widen conceptions of personalised medicine and provide education about new developments in the field.
At the conference Dr Henney, Director of the German Virtual Liver Network one of the new supporting members of the VPH Institute, released an interview on the relationship between physiology and in silico biology.
The full videois availble on YouTube.